Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000284088 | SCV000343382 | uncertain significance | not provided | 2016-07-08 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001224918 | SCV001397145 | likely benign | Bethlem myopathy 1A | 2022-11-10 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004021269 | SCV004930199 | uncertain significance | Inborn genetic diseases | 2023-10-13 | criteria provided, single submitter | clinical testing | The c.5645C>T (p.S1882L) alteration is located in exon 12 (coding exon 11) of the COL6A3 gene. This alteration results from a C to T substitution at nucleotide position 5645, causing the serine (S) at amino acid position 1882 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |